A confirmed mild cognitive disorder conferring elevated risk of future dementia progression, including Mild Cognitive Impairment (MCI) and Subjective Cognitive Impairment (SCI) Mental and Behavioural Disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. A confirmed mild cognitive disorder conferring elevated risk of future dementia progression. This includes (but is not limited to): Mild Cognitive Impairment (MCI) and Subjective Cognitive Impairment (SCI) 2. Previously seen in the Bristol Brain Centre, Southmead Hospital as a patient 3. Happy, comfortable and able to join a group with other patients 4. Willing and able to commit to travelling to the Bristol Brain Centre on a regular basis to attend a series of group sessions 5. Full capacity to provide informed consent to involvement 6. Between 50 - 90 years of age
Exclusion criteria
Exclusion criteria: 1. Montreal Cognitive Assessment (MoCA) <18/30 2. If someone has a psychiatric condition/diagnosis that would significantly impact on their ability to engage in a group, more appropriate to offer alternative support
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recruitment target measured using recruitment data at baseline assessment;Retention rate measured using participant enrolment data at post-intervention and follow-up assessments;Participant attendance measured using intervention attendance data at post-intervention assessment;Homework task adherence measured using homework data at post-intervention assessment;Session-by-session feedback measured using end-of-session questionnaires at throughout intervention delivery;Participant experience measured using programme questionnaire and feedback interview at post-intervention assessment;Acceptability of intervention measured using acceptability of intervention measure at post-intervention assessment;Intervention appropriateness measured using intervention appropriateness measure at post-intervention assessment | — |
Secondary
| Measure | Time frame |
|---|---|
| Verbal learning and memory measured using Rey Auditory Verbal Learning Test and Wechsler Memory Scale III Logical Memory at pre- and post-intervention and 3-month follow-up assessments;Non-verbal memory measured using Rey Osterrieth Complex Figure Test at pre- and post-intervention and 3-month follow-up assessments;Language generativity measured using verbal fluency tests (phonemic and semantic) at pre- and post-intervention and 3-month follow-up assessments;Psychomotor speed measured using Trail Making Test part A at pre- and post-intervention and 3-month follow-up assessments;Set-shifting/cognitive flexibility measured using Trail Making Test part B at pre- and post-intervention and 3-month follow-up assessments;Auditory-verbal working memory & attention measured using Wechsler Memory Scale III Digit Span at pre- and post-intervention and 3-month follow-up assessments;Subjective measure of memory failure measured using Everyday Memory Questionnaire – Revised at pre- and post-intervention and 3-month follow-up assessments;Knowledge, skills and confidence in managing own health measured using Partners in Health Scale and Healthy Brain Ageing Questionnaire at pre- and post-intervention and 3-month follow-up assessments;Mood and mental wellbeing measured using DASS-21 at pre- and post-intervention and 3-month follow-up assessments;Quality of Life measured using WHOQUOL-BREF at pre- and post-intervention and 3-month follow-up assessments;Sleep health measured using CogSleep Screener and Ru-SATED at pre- and post-intervention and 3-month follow-up assessments;Dementia risk index measured using CogDrisk at pre- and post-intervention and 3-month follow-up assessments | — |
Countries
England, United Kingdom